HCW Biologics Inc. (HCWB) Return on equity 2021–2025
HCW Biologics Inc. (HCWB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-287.9%FY2025 · since FY2021: -25.1% → -287.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -287.9% | — |
| FY2023 | -185.7% | -145.9 pp |
| FY2022 | -39.8% | -14.7 pp |
| FY2021 | -25.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice